Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hoeppner, US
Edward Hoeppner, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100299110 | SYSTEM AND METHOD FOR HAZARDOUS AREA CLASSIFICATION - A computer processor driven system and method capable of identifying and constructing representations of hazardous areas. The hazardous area classification system has one or more processors, and a computer readable medium containing instructions that, when executed, cause the one or more processors to perform the steps of determining a position of a hazardous area for a predetermined location using a calculation based on a plurality of parameters, and generating a representation of the hazardous area. | 11-25-2010 |
Jacy Hoeppner, Warsaw, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20080267902 | BLOOD PRODUCTS WITH BINDING AGENT - The present invention provides a non-liquid biomaterial that may be used as a surgical sealant, a suture support, a blood flow controller, an adhesion reducing agent, an adhesion preventing agent, a tissue support, a tissue filler, a wound dressing or a combination thereof. The non-liquid biomaterial may comprise a blood derived material such as plasma, platelet poor plasma, platelet rich plasma or a material derived from blood containing tissue aspirate, such as bone marrow aspirate, a protein binding agent and a polymerizing agent. Methods for making and using the non-liquid biomaterial are also provided. | 10-30-2008 |
| 20100055087 | METHODS AND COMPOSITIONS FOR DELIVERING INTERLEUKIN-1 RECEPTOR ANTAGONIST - Methods and compositions generating and using an interleukin-1 receptor antagonist (IL-1ra)-rich solution. Methods for generating and isolating interleukin-1 receptor antagonist include incubating adipose tissue and/or adipocytes with polyacrylamide beads to produce interleukin-1 receptor antagonist. The interleukin-1 receptor antagonist is isolated from the polyacrylamide beads to obtain the solution rich in interleukin-1 receptor antagonist. Methods for treating a site of inflammation in a patient include administering to the site of inflammation the solution rich in interleukin-1 receptor antagonist. | 03-04-2010 |
| 20110052561 | OSTEOLYSIS TREATMENT - Methods and treatments for osteolysis employing interleukin-1 receptor antagonist (IL-1ra). Activating production of interleukin-1 receptor antagonist includes incubating adipose tissue, adipocytes, whole blood, platelet rich plasma, and/or isolated white blood cells with polyacrylamide beads to produce a solution rich in interleukin-1 receptor antagonist. Activating the production of interleukin-1 receptor antagonist includes using an implantable device loaded with adipose tissue, adipocytes, whole blood, platelet rich plasma, and/or isolated white blood cells. Methods for treating osteolysis at the site of an artificial joint in a patient include administering and/or inserting the solution rich in interleukin-1 receptor antagonist and/or the implantable device, respectively. | 03-03-2011 |
| 20120076750 | FIBRIN BASED GLUE WITH FUNCTIONALIZED HYDROPHILIC POLYMER PROTEIN BINDING AGENT - The present invention provides a non-liquid biomaterial that may be used as a surgical sealant, a suture support, a blood flow controller, an adhesion reducing agent, an adhesion preventing agent, a tissue support, a tissue filler, a wound dressing or a combination thereof. The non-liquid biomaterial may comprise a blood derived material such as plasma, platelet poor plasma, platelet rich plasma or a material derived from blood containing tissue aspirate, such as bone marrow aspirate, a protein binding agent and a polymerizing agent. Methods for making and using the non-liquid biomaterial are also provided. | 03-29-2012 |
Kent Hoeppner, Dallas Center, IA US
| Patent application number | Description | Published |
|---|---|---|
| 20110047042 | AUTOMATED HIGH-THROUGHPUT SEED PROCESSING APPARATUS AND METHOD - An apparatus and method for automated high-throughput processing seed requests or orders includes an autonomous single seed counter and packager which operates by pre-programmed criteria. Optional features can include a thresher, a spiral separator, and a label applicator. A conveyance path, controlled automatically, can move the seed to appropriate and desired stations during the processing while maintaining segregation from subsequent seed being processed. Validation of the seed request matching the sample requested occurs prior to processing and information about the seed to process or having been processed can be derived and stored for further use. | 02-24-2011 |
Kent L. Hoeppner, Dallas Center, IA US
| Patent application number | Description | Published |
|---|---|---|
| 20100043685 | SEED PLANTER - The invention is directed to an apparatus, method and system for a seed planter. The seed planter has a planting, dispensing and metering assembly operatively attached to a mobile supporting structure. The metering assembly has separated seed pre-staging and/or staging positions for staging pre-specified counts of seed separated from other counts in the batch and maintaining separation of the pre-specified counts of seed from other counts in the batch for planting. Alternatively, the metering assembly has separated seed staging positions for staging a batch of seed in singulated form for planting. | 02-25-2010 |
Luke H. Hoeppner, Minneapolis, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100124755 | PROSTATE CANCER AND MELANOMA ANTIGENS - Methods for identifying a human subject as a candidate for further prostate cancer or melanoma examination are disclosed. Also disclosed are methods for determining whether an immune therapy has elicited a tumor-specific immune response in a prostate cancer or melanoma patient. Further disclosed are kits that can be used to practice the above methods. Methods for identifying candidate compounds for further testing as preventive or therapeutic agents for melanoma are also disclosed. | 05-20-2010 |
Luke H. Hoeppner, Rochester, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080206289 | PROSTATE CANCER AND MELANOMA ANTIGENS - Methods for identifying a human subject as a candidate for further prostate cancer or melanoma examination are disclosed. Also disclosed are methods for determining whether an immune therapy has elicited a tumor-specific immune response in a prostate cancer or melanoma patient. Further disclosed are kits that can be used to practice the above methods. Methods for identifying candidate compounds for further testing as preventive or therapeutic agents for melanoma are also disclosed. | 08-28-2008 |
Sara Hoeppner, Burnsville, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080270188 | Graphical display of patient data - A dynamic graphical display for presenting patient data received from a medical device automatically sorts the patient data into a Venn diagram type format. In one embodiment, the graphical display includes two or more graphic objects representing different types of physiological parameters or events derived from the physiological parameters. The graphic objects define at least a first section corresponding to a first subset of patient data, a second section corresponding to a second subset of patient data, and a third section corresponding to a conjunction of the first and second subsets of patient data. In some embodiments, a user may select one of the sections of the graphical display to obtain further details about the respective subset of patient data or conjunction of subsets of data. | 10-30-2008 |
Sara M. Hoeppner, Burnsville, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110184481 | STORAGE OF DATA FOR EVALUATION OF LEAD INTEGRITY - In general, the disclosure describes techniques for storing data corresponding to sensed high-rate non-sustained episodes that occur close in time to detection of a lead integrity condition. A method comprises detecting a first high-rate non-sustained episode, activating a data storage operation for storing data associated with high rate non-sustained episodes in response to detecting the first episode, and storing data associated with the first episode in an episode log in response to activating the data storage operation. Another method comprises detecting a lead integrity condition, and activating a data storage operation for storing data associated with high rate non-sustained episodes in response to detecting the condition. | 07-28-2011 |
Timothy James Hoeppner US
| Patent application number | Description | Published |
|---|---|---|
| 20120112747 | MRI Safety System - In a MRI system housed within a room there is provided a movable magnet and additional components for other procedures on the patient, a control system is provided for the relative movement of the magnet and components. This includes a plurality of magnetic field sensors mounted on the components for measuring the magnetic field at the location of the component and an optional camera positioning system so that the control system can estimate relative positions of the components relative to the magnet from the sensed field strengths from the set of sensors to avoid collisions during the movements. | 05-10-2012 |